Mirzazadeh Reza, Kallas Tomasz, Bienko Magda, Crosetto Nicola
Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Methods Mol Biol. 2018;1672:167-194. doi: 10.1007/978-1-4939-7306-4_14.
DNA double-strand breaks (DSBs) are major DNA lesions that are constantly formed during physiological processes such as DNA replication, transcription, and recombination, or as a result of exogenous agents such as ionizing radiation, radiomimetic drugs, and genome editing nucleases. Unrepaired DSBs threaten genomic stability by leading to the formation of potentially oncogenic rearrangements such as translocations. In past few years, several methods based on next-generation sequencing (NGS) have been developed to study the genome-wide distribution of DSBs or their conversion to translocation events. We developed Breaks Labeling, Enrichment on Streptavidin, and Sequencing (BLESS), which was the first method for direct labeling of DSBs in situ followed by their genome-wide mapping at nucleotide resolution (Crosetto et al., Nat Methods 10:361-365, 2013). Recently, we have further expanded the quantitative nature, applicability, and scalability of BLESS by developing Breaks Labeling In Situ and Sequencing (BLISS) (Yan et al., Nat Commun 8:15058, 2017). Here, we first present an overview of existing methods for genome-wide localization of DSBs, and then focus on the BLESS and BLISS methods, discussing different assay design options depending on the sample type and application.
DNA双链断裂(DSBs)是主要的DNA损伤,在诸如DNA复制、转录和重组等生理过程中持续形成,或者是由诸如电离辐射、放射模拟药物和基因组编辑核酸酶等外源性因素导致的。未修复的DSBs通过导致潜在致癌重排(如易位)的形成来威胁基因组稳定性。在过去几年中,已经开发了几种基于下一代测序(NGS)的方法来研究DSBs的全基因组分布或它们向易位事件的转化。我们开发了断裂标记、链霉亲和素富集和测序(BLESS),这是第一种原位直接标记DSBs然后在核苷酸分辨率下进行全基因组定位的方法(Crosetto等人,《自然方法》10:361 - 365,2013年)。最近,我们通过开发原位断裂标记和测序(BLISS)进一步扩展了BLESS的定量特性、适用性和可扩展性(Yan等人,《自然通讯》8:15058,2017年)。在这里,我们首先概述现有的DSBs全基因组定位方法,然后重点介绍BLESS和BLISS方法,根据样本类型和应用讨论不同的检测设计选项。